How Collaboration Is Driving the Next Wave of Genomics

By: 3BL Media

Illumina’s Open Innovation programs work with partners to change lives

SOURCE: Illumina




Illumina’s advances in genetic sequencing are reshaping medicine. Genetic sequencing has now allowed cancer patients to find treatment options specific to their tumors, doctors to anticipate adverse drug reactions and personalize medicine, public health agencies around the world to track and detect new COVID variants, and patients with rare diseases to more easily identify and treat their illnesses.


Through Illumina Open Innovation, Illumina is investing in new startups and partnering in research efforts to develop solutions in areas such as rapid sequencing and data security. “To really unlock the power of the genome is something we can’t do alone,” Van Zeeland says.

Read the full article here

Learn more about Illumina here

Tweet me: Learn about @illumina's Open Innovation program and how investments in new startups can create opportunities and innovations that are unlocking the power of the genome and ultimately reshaping medicine. Read the full story here:

KEYWORDS: NASDAQ: ILMN, illumina, genomics, Genetic Sequencing, Cancer patients, Illumina Open Innovation, Ashley Van Zeeland

“Our open innovation and philanthropic efforts will make sure [that] transformative innovations are actually getting out and changing lives,” says Illumina VP Ashley Van Zeeland. Photography by Kristy Walker.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.